SCHEMBL3399416

SCHEMBL3399416

COc1cccc(N=C=O)c1I

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
CA1 P00915 4/20 0.37
CA2 P00918 4/20 0.37
CA7 P43166 3/20 0.37
CA9 Q16790 3/20 0.37
CA12 O43570 2/20 0.37
CA14 Q9ULX7 2/20 0.37
CA4 P22748 1/20 0.37
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
HSD17B10 Q99714 2/20 0.34
TP53 P04637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL77114 0.81 ALDH1A1 (0.61) CYP3A4ALDH1A1HPGDTDP1CA1
SCHEMBL29471398 0.81 ALDH1A1 (0.61) CYP3A4ALDH1A1HPGDTDP1CA1
SCHEMBL2169591 0.80 CYP3A4 (0.52) CYP3A4ALDH1A1HPGDTDP1CA1
SCHEMBL1332133 0.80 CYP3A4 (0.57) CYP3A4ALDH1A1HPGDTDP1CA1
SCHEMBL30438740 0.80 CYP3A4 (0.57) CYP3A4ALDH1A1HPGDTDP1CA1
SCHEMBL4726617 0.80 CYP3A4 (0.68) CYP3A4ALDH1A1HPGDTDP1CA1
SCHEMBL3548169 0.79 CYP3A4 (0.50) CYP3A4ALDH1A1HPGDTDP1CA1
SCHEMBL4056709 0.79 CYP3A4 (0.50) CYP3A4ALDH1A1HPGDTDP1CA1
SCHEMBL11042151 0.76 CYP3A4 (0.47) CYP3A4ALDH1A1HPGDTDP1CA1
SCHEMBL3399670 0.76 CYP3A4 (0.61) CYP3A4ALDH1A1HPGDTDP1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2244574-A1 TRICYCLIC COMPOUNDS AS MODULATORS OF TNF- SYNTHESIS AND AS PDE4 INHIBITORS High Point Pharmaceuticals, LLC (US) 2010-11-03 EP disclosed
WO-2009094528-A1 TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-α SYNTHESIS AND AS PDE4 INHIBITORS HIGH POINT PHARMACEUTICALS, LLC (US) 2009-07-30 WO disclosed